| EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update JS Smolen, R Landewé, FC Breedveld, M Buch, G Burmester, ... Annals of the rheumatic diseases 73 (3), 492-509, 2014 | 5539* | 2014 |
| Extrapulmonary manifestations of COVID-19 A Gupta, MV Madhavan, K Sehgal, N Nair, S Mahajan, TS Sehrawat, ... Nature medicine 26 (7), 1017-1032, 2020 | 3569 | 2020 |
| A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis JM Bathon, RW Martin, RM Fleischmann, JR Tesser, MH Schiff, ... New England Journal of Medicine 343 (22), 1586-1593, 2000 | 2430 | 2000 |
| American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials DT Felson, JS Smolen, G Wells, B Zhang, LHD Van Tuyl, J Funovits, ... Arthritis & Rheumatism 63 (3), 573-586, 2011 | 1932 | 2011 |
| Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial EW St. Clair, DMFM Van Der Heijde, JS Smolen, RN Maini, JM Bathon, ... Arthritis & Rheumatism 50 (11), 3432-3443, 2004 | 1549 | 2004 |
| 2021 American College of Rheumatology guideline for the treatment of rheumatoid arthritis L Fraenkel, JM Bathon, BR England, EW St. Clair, T Arayssi, K Carandang, ... Arthritis & Rheumatology 73 (7), 1108-1123, 2021 | 1143 | 2021 |
| EULAR recommendations for the management of Behçet disease G Hatemi, A Silman, D Bang, B Bodaghi, AM Chamberlain, A Gul, ... Annals of the rheumatic diseases 67 (12), 1656-1662, 2008 | 1010 | 2008 |
| Etanercept versus methotrexate in patients with early rheumatoid arthritis: two‐year radiographic and clinical outcomes MC Genovese, JM Bathon, RW Martin, RM Fleischmann, JR Tesser, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2002 | 988 | 2002 |
| Catastrophizing and pain in arthritis, fibromyalgia, and other rheumatic diseases RR Edwards, CO Bingham III, J Bathon, JA Haythornthwaite Arthritis Care & Research: Official Journal of the American College of …, 2006 | 710 | 2006 |
| EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update JS Smolen, RBM Landewé, SA Bergstra, A Kerschbaumer, A Sepriano, ... Annals of the rheumatic diseases 82 (1), 3-18, 2023 | 675 | 2023 |
| Predictors of joint damage in patients with early rheumatoid arthritis treated with high‐dose methotrexate with or without concomitant infliximab: results from the ASPIRE trial JS Smolen, DMFM Van Der Heijde, EW St. Clair, P Emery, JM Bathon, ... Arthritis & Rheumatism 54 (3), 702-710, 2006 | 564 | 2006 |
| Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate: a randomized, double-blind, placebo-controlled trial JM Kremer, MC Genovese, GW Cannon, JR Caldwell, JJ Cush, DE Furst, ... Annals of internal medicine 137 (9), 726-733, 2002 | 521 | 2002 |
| A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: the treatment of Early … LW Moreland, JR O'Dell, HE Paulus, JR Curtis, JM Bathon, EW St. Clair, ... Arthritis & Rheumatism 64 (9), 2824-2835, 2012 | 495 | 2012 |
| Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations D Aletaha, R Landewe, T Karonitsch, J Bathon, M Boers, C Bombardier, ... Arthritis Care & Research: Official Journal of the American College of …, 2008 | 492 | 2008 |
| Clinical efficacy and safety of abatacept in methotrexate-naive patients with early rheumatoid arthritis and poor prognostic factors R Westhovens, M Robles, AC Ximenes, S Nayiager, J Wollenhaupt, ... Annals of the rheumatic diseases 68 (12), 1870-1877, 2009 | 457 | 2009 |
| Safety and efficacy of additional courses of rituximab in patients with active rheumatoid arthritis: an open‐label extension analysis E Keystone, R Fleischmann, P Emery, DE Furst, R Van Vollenhoven, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2007 | 437 | 2007 |
| Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study IB McInnes, L Thompson, JT Giles, JM Bathon, JE Salmon, AD Beaulieu, ... Annals of the rheumatic diseases 74 (4), 694-702, 2015 | 350 | 2015 |
| Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of … JS Smolen, C Han, DMFM van der Heijde, P Emery, JM Bathon, ... Annals of the rheumatic diseases 68 (6), 823-827, 2009 | 350 | 2009 |
| Tumor necrosis factor inhibitor therapy and risk of serious postoperative orthopedic infection in rheumatoid arthritis JT Giles, SJ Bartlett, AC Gelber, S Nanda, K Fontaine, V Ruffing, ... Arthritis Care & Research: Official Journal of the American College of …, 2006 | 317 | 2006 |
| Abnormal body composition phenotypes in older rheumatoid arthritis patients: association with disease characteristics and pharmacotherapies JT Giles, SM Ling, L Ferrucci, SJ Bartlett, RE Andersen, M Towns, ... Arthritis Care & Research: Official Journal of the American College of …, 2008 | 286 | 2008 |
